CongressBuys

Congress trades in Genmab A/S (GMAB)

Healthcare · Biotechnology

4 members of Congress have disclosed 12 trades in Genmab A/S (GMAB) since 2020: 8 buys and 4 sales. The most recent was disclosed on Jul 21, 2026. 1 trade was made by members of a committee that oversees Genmab A/S's industry.

Trades disclosed
12
Members trading
4
Buys / sells
8 / 4
Reported value
$61K–$265K

Committee overlaps

Trades by members of a committee that oversees Genmab A/S's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded GMAB

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.